About My Health Careers Internship MedBlogs Contact us

Blood-thinning Drugs Can Reduce Dementia Risk in Atrial Fibrillation Patients

by Hannah Joy on October 25, 2017 at 1:06 PM
Font : A-A+

Blood-thinning Drugs Can Reduce Dementia Risk in Atrial Fibrillation Patients

Blood-thinning drugs that reduce the risk of stroke in patients with atrial fibrillation (AF) was found to reduce the risk of dementia as well, reveals a new study.

Among 444,106 patients with atrial fibrillation (an abnormal heart rhythm), those who were taking anticoagulant drugs to prevent blood clots at the start of the study had a 29% lower risk of developing dementia than patients who were not on anticoagulant treatment. When the researchers looked at what happened during the period of time that the patients continued to take the drugs, they found an even bigger, 48% reduction in the risk of dementia.


The new research was published in the European Heart Journal. This is the largest study ever to examine the link between anticoagulant treatment and dementia in AF patients. It looked at data from Swedish registries for patients between 2006 and 2014, and, despite its retrospective nature, which means it cannot show causal effect, the researchers believe that the results strongly suggest that oral anticoagulants protect against dementia in AF patients.

"In order to prove this assumption, randomized placebo controlled trials would be needed, but such studies cannot be done because of ethical reasons. It is not possible to give placebo to AF patients and then wait for dementia or stroke to occur," write Leif Friberg and Mårten Rosenqvist from the Karolinska Institute (Stockholm, Sweden) in their EHJ paper.

AF is known to carry an increased risk of stroke and dementia, and anticoagulants have been shown to reduce the likelihood of stroke. Until now it was not clear whether anticoagulants could also prevent dementia; however, it was thought possible because if the drugs can prevent the big blood clots that cause stroke, they might also protect against the small clots that can cause unnoticed microscopic strokes that eventually lead to cognitive deterioration.

The researchers identified all patients in Sweden who had a diagnosis of AF between 2006-2014. They checked on what drugs had been prescribed and dispensed following the diagnosis. They followed the patients' progress and this provided them with 1.5 million years of follow-up, during which time 26,210 patients were diagnosed with dementia.

When they first joined the study, 54 percent of patients were not taking oral anticoagulants such as warfarin, apixaban, dabigatran, edoxaban or rivaroxaban. The researchers found that the strongest predictors for dementia were lack of oral anticoagulant treatment, aging, Parkinson's disease and alcohol abuse. They also found that the sooner oral anticoagulant treatment was started after a diagnosis of AF, the greater was the protective effect against dementia.

Dr Friberg, who is associate professor of cardiology at the Karolinska Institute, said the important implications from these findings were that patients should be started on oral anticoagulant drugs as soon as possible after diagnosis of AF and that they should continue to take the drugs.

"Doctors should not tell their patients to stop using oral anticoagulants without a really good reason. Explain to your patients how these drugs work and why they should use them. An informed patient who understands this is much more likely to comply and will be able to use the drugs safely and get better benefits. To patients I would say 'don't stop unless your doctor says so. Have your doctor explain why you should take the drug so that you feel you understand and agree'.

"Patients start on oral anticoagulation for stroke prevention but they stop after a few years at an alarmingly high rate. In the first year, approximately 15% stop taking the drugs, then approximately 10% each year.

In this study we found that only 54% of patients were on oral anticoagulant treatment. If you know that AF eats away your brain at a slow but steady pace and that you can prevent it by staying on treatment, I think most AF patients would find this a very strong argument for continuing treatment.

"As a clinician I know there are AF patients who have a fatalistic view upon stroke. Either it happens or it does not. Few patients are fatalistic about dementia, which gradually makes you lose your mind. No brain can withstand a constant bombardment of microscopic clots in the long run. Patients probably want to hang on to as many of their little grey cells for as long as they can. In order to preserve what you've got, you should take care to use anticoagulants if you are diagnosed with AF, as they have been proved to protect against stroke and, which this study indicates, also appear to protect against dementia."

The study also found that there was no difference in dementia prevention between the older blood-thinning drug warfarin and the newer oral anticoagulants.

In addition to the fact that this study cannot prove or disprove a causal relationship between oral anticoagulants and dementia, some other limitations include the lack of complete medical histories for the patients, including details of other diseases, and the fact that dementia is insidious and is not necessarily diagnosed immediately, meaning that the true prevalence of dementia is probably higher than reported.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alzheimers Disease Drug Toxicity Palpitations And Arrhythmias Drugs Banned in India Atrial Fibrillation Dementia Vascular Dementia Cardiac Ablation Drugs for Atrial Fibrillation 

Recommended Reading
New Anticoagulants May Not Be Associated With Higher Risk of Bleeding
Direct oral anticoagulants are now being used as an alternative to warfarin and are not associated ....
Preoperative Use of Blood-Thinners is Safe for Cancer Patients
Among patients undergoing major cancer operations, the preoperative use of blood-thinning drugs ......
Women with Atrial Fibrillation Less Likely to Use Oral Anticoagulants
Women are less likely to use oral anticoagulants in treating atrial fibrillation (AFib) due to ......
Management of Anticoagulant-Associated Intracerebral Hemorrhage Highlighted
A supplement to the August issue entitled "Race Against the Clock: Overcoming Challenges in the ......
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and mak...
Atrial Fibrillation
Atrial fibrillation may not be life-threatening in itself but it is important to understand the caus...
Cardiac Ablation
Cardiac Ablation is a minimally invasive heart procedure, which involves identifying and scarring th...
Dementia has become a very big concern as we have an aging population across the world. Dementia is ...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Drugs for Atrial Fibrillation
Atrial fibrillation is a condition with irregular heart rhythm. Be aware of the prescribed drugs, th...
Palpitations And Arrhythmias
Palpitations are unpleasant sensation of one’s own heartbeat....
Vascular Dementia
Vascular dementia is the second most common form of dementia. Though it has no cure, you can still l...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use